scispace - formally typeset
H

Hiroaki Konishi

Researcher at Jichi Medical University

Publications -  77
Citations -  1833

Hiroaki Konishi is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Transplantation & Mitral valve. The author has an hindex of 19, co-authored 76 publications receiving 1773 citations. Previous affiliations of Hiroaki Konishi include University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management

TL;DR: Recipients with obliterative bronchiolitis detected in the preclinical stage were significantly more likely to be in remission than recipients who had clinical disease at the time of diagnosis and results indicate that acute rejection is the most significant risk factor for development of obliteration and that obliteration responds to treatment with augmented immunosuppression when it is detected early by surveillance transbronchial biopsy.
Journal ArticleDOI

Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation.

TL;DR: The hazard for death, infection, and rejection after pulmonary transplantation appears biphasic, and prevention of cytomegalovirus disease should improve survival by decreasing the prevalence of infection and rejection.
Journal ArticleDOI

Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension.

TL;DR: Bilateral lung transplantation may be a more satisfactory option for patients with pulmonary hypertension with simple congenital heart disease, absent coronary arterial disease, and preserved left ventricular function.
Journal ArticleDOI

A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation.

TL;DR: Although the presence of bacterial, fungal, and viral infections was similar in the two groups, ACR occurred less frequently in the FK- treated group as compared with the CsA-treated group in the early postoperative period (< 90 days).
Journal ArticleDOI

Impact of pulmonary hypertension on outcome after single-lung transplantation

TL;DR: Despite a shortage of donor organs, single-lung transplantation may be suboptimal therapy in patients with PH, and further study comparing single versus bilateral lung transplantation for PH is necessary.